Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Inmunoterapia para el tumor urotelial
El cáncer urotelial (CU) de la vejiga, pelvis renal, ureter y otros órganos urinarios es muy común en los estados unidos. La inmunoterapia ha proporcionado buenos resultados en pacientes con CU avanzado. (Immunotherapy for Urothelial Cancer Fact Sheet)